Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Francisella tularensis enters a double membraned compartment following cell-cell transfer.

Steele SP, Chamberlain Z, Park J, Kawula TH.

Elife. 2019 Apr 24;8. pii: e45252. doi: 10.7554/eLife.45252.

2.

Defining the Metabolic Pathways and Host-Derived Carbon Substrates Required for Francisella tularensis Intracellular Growth.

Radlinski LC, Brunton J, Steele S, Taft-Benz S, Kawula TH.

MBio. 2018 Nov 20;9(6). pii: e01471-18. doi: 10.1128/mBio.01471-18.

3.

A Phosphatidylinositol 3-Kinase Effector Alters Phagosomal Maturation to Promote Intracellular Growth of Francisella.

Ledvina HE, Kelly KA, Eshraghi A, Plemel RL, Peterson SB, Lee B, Steele S, Adler M, Kawula TH, Merz AJ, Skerrett SJ, Celli J, Mougous JD.

Cell Host Microbe. 2018 Aug 8;24(2):285-295.e8. doi: 10.1016/j.chom.2018.07.003. Epub 2018 Jul 26.

PMID:
30057173
4.

Genetic requirements for Staphylococcus aureus nitric oxide resistance and virulence.

Grosser MR, Paluscio E, Thurlow LR, Dillon MM, Cooper VS, Kawula TH, Richardson AR.

PLoS Pathog. 2018 Mar 19;14(3):e1006907. doi: 10.1371/journal.ppat.1006907. eCollection 2018 Mar.

5.

Trogocytosis-associated cell to cell spread of intracellular bacterial pathogens.

Steele S, Radlinski L, Taft-Benz S, Brunton J, Kawula TH.

Elife. 2016 Jan 23;5. pii: e10625. doi: 10.7554/eLife.10625.

6.

Extragenic suppressor mutations in ΔripA disrupt stability and function of LpxA.

Miller CN, Steele SP, Brunton JC, Jenkins RJ, LoVullo ED, Taft-Benz SA, Romanchuk A, Jones CD, Dotson GD, Collins EJ, Kawula TH.

BMC Microbiol. 2014 Dec 31;14:336. doi: 10.1186/s12866-014-0336-x.

7.

The antipsychotic olanzapine interacts with the gut microbiome to cause weight gain in mouse.

Morgan AP, Crowley JJ, Nonneman RJ, Quackenbush CR, Miller CN, Ryan AK, Bogue MA, Paredes SH, Yourstone S, Carroll IM, Kawula TH, Bower MA, Sartor RB, Sullivan PF.

PLoS One. 2014 Dec 15;9(12):e115225. doi: 10.1371/journal.pone.0115225. eCollection 2014.

8.

Identification of early interactions between Francisella and the host.

Roberts LM, Tuladhar S, Steele SP, Riebe KJ, Chen CJ, Cumming RI, Seay S, Frothingham R, Sempowski GD, Kawula TH, Frelinger JA.

Infect Immun. 2014 Jun;82(6):2504-10. doi: 10.1128/IAI.01654-13. Epub 2014 Mar 31.

9.

Infection with Francisella tularensis LVS clpB leads to an altered yet protective immune response.

Barrigan LM, Tuladhar S, Brunton JC, Woolard MD, Chen CJ, Saini D, Frothingham R, Sempowski GD, Kawula TH, Frelinger JA.

Infect Immun. 2013 Jun;81(6):2028-42. doi: 10.1128/IAI.00207-13. Epub 2013 Mar 25.

10.

Identification of Francisella novicida mutants that fail to induce prostaglandin E(2) synthesis by infected macrophages.

Woolard MD, Barrigan LM, Fuller JR, Buntzman AS, Bryan J, Manoil C, Kawula TH, Frelinger JA.

Front Microbiol. 2013 Feb 11;4:16. doi: 10.3389/fmicb.2013.00016. eCollection 2013.

11.

PanG, a new ketopantoate reductase involved in pantothenate synthesis.

Miller CN, LoVullo ED, Kijek TM, Fuller JR, Brunton JC, Steele SP, Taft-Benz SA, Richardson AR, Kawula TH.

J Bacteriol. 2013 Mar;195(5):965-76. doi: 10.1128/JB.01740-12. Epub 2012 Dec 14.

12.

TetR-based gene regulation systems for Francisella tularensis.

LoVullo ED, Miller CN, Pavelka MS Jr, Kawula TH.

Appl Environ Microbiol. 2012 Oct;78(19):6883-9. doi: 10.1128/AEM.01679-12. Epub 2012 Jul 20.

13.

Francisella tularensis RipA protein topology and identification of functional domains.

Mortensen BL, Fuller JR, Taft-Benz S, Collins EJ, Kawula TH.

J Bacteriol. 2012 Mar;194(6):1474-84. doi: 10.1128/JB.06327-11. Epub 2012 Jan 20.

14.

A broadly applicable approach to T cell epitope identification: application to improving tumor associated epitopes and identifying epitopes in complex pathogens.

Valentino MD, Abdul-Alim CS, Maben ZJ, Skrombolas D, Hensley LL, Kawula TH, Dziejman M, Lord EM, Frelinger JA, Frelinger JG.

J Immunol Methods. 2011 Oct 28;373(1-2):111-26. doi: 10.1016/j.jim.2011.08.007. Epub 2011 Aug 18.

15.

Identification of T-cell epitopes in Francisella tularensis using an ordered protein array of serological targets.

Valentino MD, Maben ZJ, Hensley LL, Woolard MD, Kawula TH, Frelinger JA, Frelinger JG.

Immunology. 2011 Mar;132(3):348-60. doi: 10.1111/j.1365-2567.2010.03387.x. Epub 2011 Jan 7.

16.

Deletion of ripA alleviates suppression of the inflammasome and MAPK by Francisella tularensis.

Huang MT, Mortensen BL, Taxman DJ, Craven RR, Taft-Benz S, Kijek TM, Fuller JR, Davis BK, Allen IC, Brickey WJ, Gris D, Wen H, Kawula TH, Ting JP.

J Immunol. 2010 Nov 1;185(9):5476-85. doi: 10.4049/jimmunol.1002154. Epub 2010 Oct 4.

17.

Effects of the putative transcriptional regulator IclR on Francisella tularensis pathogenesis.

Mortensen BL, Fuller JR, Taft-Benz S, Kijek TM, Miller CN, Huang MT, Kawula TH.

Infect Immun. 2010 Dec;78(12):5022-32. doi: 10.1128/IAI.00544-10. Epub 2010 Oct 4.

18.

Environmental and intracellular regulation of Francisella tularensis ripA.

Fuller JR, Kijek TM, Taft-Benz S, Kawula TH.

BMC Microbiol. 2009 Oct 12;9:216. doi: 10.1186/1471-2180-9-216.

19.

TAM receptors are dispensable in the phagocytosis and killing of bacteria.

Williams JC, Craven RR, Earp HS, Kawula TH, Matsushima GK.

Cell Immunol. 2009;259(2):128-34. doi: 10.1016/j.cellimm.2009.06.006. Epub 2009 Jun 21.

20.

The impact of chemokine receptor CX3CR1 deficiency during respiratory infections with Mycobacterium tuberculosis or Francisella tularensis.

Hall JD, Kurtz SL, Rigel NW, Gunn BM, Taft-Benz S, Morrison JP, Fong AM, Patel DD, Braunstein M, Kawula TH.

Clin Exp Immunol. 2009 May;156(2):278-84. doi: 10.1111/j.1365-2249.2009.03882.x. Epub 2009 Feb 10.

21.

Identification of a dominant CD4 T cell epitope in the membrane lipoprotein Tul4 from Francisella tularensis LVS.

Valentino MD, Hensley LL, Skrombolas D, McPherson PL, Woolard MD, Kawula TH, Frelinger JA, Frelinger JG.

Mol Immunol. 2009 May;46(8-9):1830-8. doi: 10.1016/j.molimm.2009.01.008. Epub 2009 Feb 23.

22.

Infected-host-cell repertoire and cellular response in the lung following inhalation of Francisella tularensis Schu S4, LVS, or U112.

Hall JD, Woolard MD, Gunn BM, Craven RR, Taft-Benz S, Frelinger JA, Kawula TH.

Infect Immun. 2008 Dec;76(12):5843-52. doi: 10.1128/IAI.01176-08. Epub 2008 Oct 13.

23.

RipA, a cytoplasmic membrane protein conserved among Francisella species, is required for intracellular survival.

Fuller JR, Craven RR, Hall JD, Kijek TM, Taft-Benz S, Kawula TH.

Infect Immun. 2008 Nov;76(11):4934-43. doi: 10.1128/IAI.00475-08. Epub 2008 Sep 2.

24.

Francisella tularensis invasion of lung epithelial cells.

Craven RR, Hall JD, Fuller JR, Taft-Benz S, Kawula TH.

Infect Immun. 2008 Jul;76(7):2833-42. doi: 10.1128/IAI.00043-08. Epub 2008 Apr 21.

25.

Respiratory Francisella tularensis live vaccine strain infection induces Th17 cells and prostaglandin E2, which inhibits generation of gamma interferon-positive T cells.

Woolard MD, Hensley LL, Kawula TH, Frelinger JA.

Infect Immun. 2008 Jun;76(6):2651-9. doi: 10.1128/IAI.01412-07. Epub 2008 Apr 7.

26.

An immunoaffinity tandem mass spectrometry (iMALDI) assay for detection of Francisella tularensis.

Jiang J, Parker CE, Fuller JR, Kawula TH, Borchers CH.

Anal Chim Acta. 2007 Dec 12;605(1):70-9. Epub 2007 Oct 23.

27.

Genome-wide identification of Francisella tularensis virulence determinants.

Su J, Yang J, Zhao D, Kawula TH, Banas JA, Zhang JR.

Infect Immun. 2007 Jun;75(6):3089-101. Epub 2007 Apr 9.

28.

Francisella tularensis-infected macrophages release prostaglandin E2 that blocks T cell proliferation and promotes a Th2-like response.

Woolard MD, Wilson JE, Hensley LL, Jania LA, Kawula TH, Drake JR, Frelinger JA.

J Immunol. 2007 Feb 15;178(4):2065-74.

29.

Francisella tularensis replicates within alveolar type II epithelial cells in vitro and in vivo following inhalation.

Hall JD, Craven RR, Fuller JR, Pickles RJ, Kawula TH.

Infect Immun. 2007 Feb;75(2):1034-9. Epub 2006 Nov 6.

30.

Expression of Haemophilus ducreyi collagen binding outer membrane protein NcaA is required for virulence in swine and human challenge models of chancroid.

Fulcher RA, Cole LE, Janowicz DM, Toffer KL, Fortney KR, Katz BP, Orndorff PE, Spinola SM, Kawula TH.

Infect Immun. 2006 May;74(5):2651-8.

31.

Use of transposon-transposase complexes to create stable insertion mutant strains of Francisella tularensis LVS.

Kawula TH, Hall JD, Fuller JR, Craven RR.

Appl Environ Microbiol. 2004 Nov;70(11):6901-4.

32.

A humoral immune response confers protection against Haemophilus ducreyi infection.

Cole LE, Toffer KL, Fulcher RA, San Mateo LR, Orndorff PE, Kawula TH.

Infect Immun. 2003 Dec;71(12):6971-7.

33.

The Haemophilus ducreyi serum resistance antigen DsrA confers attachment to human keratinocytes.

Cole LE, Kawula TH, Toffer KL, Elkins C.

Infect Immun. 2002 Nov;70(11):6158-65.

34.

A superoxide dismutase C mutant of Haemophilus ducreyi is virulent in human volunteers.

Bong CT, Fortney KR, Katz BP, Hood AF, San Mateo LR, Kawula TH, Spinola SM.

Infect Immun. 2002 Mar;70(3):1367-71.

36.
37.

Immune cells are required for cutaneous ulceration in a swine model of chancroid.

San Mateo LR, Toffer KL, Orndorff PE, Kawula TH.

Infect Immun. 1999 Sep;67(9):4963-7.

41.

The sodA gene of Haemophilus ducreyi encodes a hydrogen peroxide-inhibitable superoxide dismutase.

San Mateo LR, Toffer KL, Kawula TH.

Gene. 1998 Jan 30;207(2):251-7.

PMID:
9511768
42.

Periplasmic copper-zinc superoxide dismutase protects Haemophilus ducreyi from exogenous superoxide.

San Mateo LR, Hobbs MM, Kawula TH.

Mol Microbiol. 1998 Jan;27(2):391-404.

43.
44.

Organization of the Haemophilus ducreyi 35000 chromosome.

Hobbs MM, Leonardi MJ, Zaretzky FR, Wang TH, Kawula TH.

Microbiology. 1996 Sep;142 ( Pt 9):2587-94.

PMID:
8828227
45.
46.
47.

Swine model of Haemophilus ducreyi infection.

Hobbs MM, San Mateo LR, Orndorff PE, Almond G, Kawula TH.

Infect Immun. 1995 Aug;63(8):3094-100.

49.
50.

Characterization of the neisserial lipid-modified azurin bearing the H.8 epitope.

Woods JP, Dempsey JF, Kawula TH, Barritt DS, Cannon JG.

Mol Microbiol. 1989 May;3(5):583-91.

PMID:
2474741

Supplemental Content

Loading ...
Support Center